EFG Asset Management (Americas)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-133,692
Closed -$6.43M 121
2016
Q2
$6.43M Sell
133,692
-29,205
-18% -$1.39M 3.03% 5
2016
Q1
$7.43M Buy
+162,897
New +$7.62M 3.72% 5

Other funds holding IHE

EFG Asset Management (Americas)'s IHE Position: Q3 2016 in Review

EFG Asset Management (Americas) sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2016, closing a stake of 133,692 shares — an estimated $6.43M sold.

EFG Asset Management (Americas) first reported a position in IHE in Q1 2016 and held it in 2 quarters. The position peaked at $7.43M in Q1 2016. 84 funds tracked by Wall St. Rank hold IHE as of Q3 2016.

  • EFG Asset Management (Americas) reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 133,692 iShares US Pharmaceuticals ETF shares in Q3 2016, an estimated $6.43M.
  • EFG Asset Management (Americas) first reported a position in iShares US Pharmaceuticals ETF in Q1 2016 and held it in 2 quarters.
  • EFG Asset Management (Americas)'s iShares US Pharmaceuticals ETF position peaked at $7.43M in Q1 2016.
  • 84 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2016.

Based on EFG Asset Management (Americas)'s 13F filing for Q3 2016, filed 14 Nov 2016.